Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis

Ana Hipólito1,2, Filipa Martins1,2, Cindy Mendes1,2

  • 1CEDOC, Chronic Diseases Research Centre, NOVA Medical School|Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa, Portugal.

Frontiers in Oncology
|June 21, 2021
PubMed

Insights

Metastasis, a major cause of cancer deaths, involves cancer cell spread and secondary tumor formation. This review explores how cancer cell metabolism and signaling pathways drive metastasis, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Cancer Biology
  • Metabolic Pathways

Background:

  • Metastasis is the primary cause of cancer mortality, yet its underlying mechanisms remain incompletely understood.
  • Cancer cell dissemination, adaptation to foreign microenvironments, and secondary tumor formation are key steps in metastatic disease.
  • Metastatic progression is increasingly linked to altered cellular metabolism and reprogrammed signaling pathways.

Purpose of the Study:

  • To review the molecular mechanisms coordinating the interplay between metastatic signaling and cellular metabolism.
  • To summarize recent findings on metabolic pathways crucial for metastatic cell bioenergetics and biosynthesis.
  • To highlight emerging metabolism-based therapeutic strategies for inhibiting metastasis.

Main Methods:

  • Literature review of current research on cancer metastasis and cellular metabolism.
  • Analysis of molecular mechanisms linking signaling pathways to metabolic reprogramming in metastatic cancer cells.
  • Synthesis of findings on key metabolic pathways supporting metastatic phenotypes.

Main Results:

  • Metastatic signaling pathways significantly reprogram cellular metabolism to support cancer cell survival and proliferation.
  • Specific metabolic pathways, including those involved in bioenergetics and biosynthesis, are critical for metastatic cells.
  • Metabolic adaptations enable cancer cells to overcome microenvironmental challenges during dissemination and colonization.

Conclusions:

  • Understanding the crosstalk between metastatic signaling and metabolism is crucial for deciphering metastatic disease.
  • Targeting metabolic pathways presents a promising therapeutic avenue for combating cancer metastasis.
  • Metabolism-based strategies offer potential for developing novel anti-metastatic treatments.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K